Cargando…
THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY
Virus-free filtrate, obtained from suspensions of vaccine virus-infected dermal pulp of rabbits and rich in the soluble substances of vaccinia, was shown to contain four distinct components in electrophoresis experiments. Electrophoretic and serological observations served as a guide in developing a...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1942
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2135242/ https://www.ncbi.nlm.nih.gov/pubmed/19871174 |
_version_ | 1782142850594504704 |
---|---|
author | Shedlovsky, Theodore Smadel, Joseph E. |
author_facet | Shedlovsky, Theodore Smadel, Joseph E. |
author_sort | Shedlovsky, Theodore |
collection | PubMed |
description | Virus-free filtrate, obtained from suspensions of vaccine virus-infected dermal pulp of rabbits and rich in the soluble substances of vaccinia, was shown to contain four distinct components in electrophoresis experiments. Electrophoretic and serological observations served as a guide in developing a method for separating these components from one another. This method depended upon changes in the solubilities of the components with alterations of pH. Three of the four components appeared to be serologically inert when tested with anti-vaccinia sera. All of the L- and S-activity was found to be associated with a single component which was electrically homogeneous at several values of pH and which was homogeneous in the ultracentrifuge. This single substance, designated as LS-antigen, precipitates in equal titers with optimal amounts of L- and of S-antibody and is completely removed from solution by absorption with either antibody. The LS-antigen of vaccinia appears to be a protein molecule with two antigenically distinct parts, L and S. Heating modifies the L-portion in such a manner that the substance no longer precipitates with L-antibody; this degraded antigen still combines with L-antibody, as is shown by inhibition tests, and still precipitates with S-antibody. Similarly, treatment with heat and dilute alkali modifies the S-portion of LS-antigen so that it combines but does not precipitate with S-antibody; and at the same time all recognizable immunological properties of the L-portion are destroyed. |
format | Text |
id | pubmed-2135242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1942 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21352422008-04-18 THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY Shedlovsky, Theodore Smadel, Joseph E. J Exp Med Article Virus-free filtrate, obtained from suspensions of vaccine virus-infected dermal pulp of rabbits and rich in the soluble substances of vaccinia, was shown to contain four distinct components in electrophoresis experiments. Electrophoretic and serological observations served as a guide in developing a method for separating these components from one another. This method depended upon changes in the solubilities of the components with alterations of pH. Three of the four components appeared to be serologically inert when tested with anti-vaccinia sera. All of the L- and S-activity was found to be associated with a single component which was electrically homogeneous at several values of pH and which was homogeneous in the ultracentrifuge. This single substance, designated as LS-antigen, precipitates in equal titers with optimal amounts of L- and of S-antibody and is completely removed from solution by absorption with either antibody. The LS-antigen of vaccinia appears to be a protein molecule with two antigenically distinct parts, L and S. Heating modifies the L-portion in such a manner that the substance no longer precipitates with L-antibody; this degraded antigen still combines with L-antibody, as is shown by inhibition tests, and still precipitates with S-antibody. Similarly, treatment with heat and dilute alkali modifies the S-portion of LS-antigen so that it combines but does not precipitate with S-antibody; and at the same time all recognizable immunological properties of the L-portion are destroyed. The Rockefeller University Press 1942-01-31 /pmc/articles/PMC2135242/ /pubmed/19871174 Text en Copyright © Copyright, 1942, by The Rockefeller Institute for Medical Research New York This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Shedlovsky, Theodore Smadel, Joseph E. THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY |
title | THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY |
title_full | THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY |
title_fullStr | THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY |
title_full_unstemmed | THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY |
title_short | THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY |
title_sort | ls-antigen of vaccinia : ii. isolation of a single substance containing both l- and s-activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2135242/ https://www.ncbi.nlm.nih.gov/pubmed/19871174 |
work_keys_str_mv | AT shedlovskytheodore thelsantigenofvacciniaiiisolationofasinglesubstancecontainingbothlandsactivity AT smadeljosephe thelsantigenofvacciniaiiisolationofasinglesubstancecontainingbothlandsactivity AT shedlovskytheodore lsantigenofvacciniaiiisolationofasinglesubstancecontainingbothlandsactivity AT smadeljosephe lsantigenofvacciniaiiisolationofasinglesubstancecontainingbothlandsactivity |